Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types

Matthew C. Pahl,Carole Le Coz,Chun Su,Prabhat Sharma,Rajan M. Thomas,James A. Pippin,Emylette Cruz Cabrera,Matthew E. Johnson,Michelle E. Leonard,Sumei Lu,Alessandra Chesi,Kathleen E. Sullivan,Neil Romberg,Struan F. A. Grant,Andrew D. Wells
DOI: https://doi.org/10.1186/s13059-022-02691-1
IF: 17.906
2022-06-05
Genome Biology
Abstract:SARS-CoV-2 infection results in a broad spectrum of COVID-19 disease, from mild or no symptoms to hospitalization and death. COVID-19 disease severity has been associated with some pre-existing conditions and the magnitude of the adaptive immune response to SARS-CoV-2, and a recent genome-wide association study (GWAS) of the risk of critical illness revealed a significant genetic component. To gain insight into how human genetic variation attenuates or exacerbates disease following SARS-CoV-2 infection, we implicated putatively functional COVID risk variants in the cis-regulatory landscapes of human immune cell types with established roles in disease severity and used high-resolution chromatin conformation capture to map these disease-associated elements to their effector genes.
genetics & heredity,biotechnology & applied microbiology
What problem does this paper attempt to address?